<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05790265</url>
  </required_header>
  <id_info>
    <org_study_id>22-2375</org_study_id>
    <nct_id>NCT05790265</nct_id>
  </id_info>
  <brief_title>Assessing Innovative Wireless and Wearable Sensors for Continuous Blood Pressure Measurement in Obese Pregnant Women</brief_title>
  <official_title>Assessing Innovative Wireless and Wearable Sensors for Continuous Blood Pressure Measurement in Obese and Super-obese Pregnant Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sibel Health Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of North Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sibel Health Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective study targeting at least 20 obese and super-obese patients&#xD;
      admitted to Labor &amp; Delivery (L&amp;D) for delivery at UNC Medical Center. Patients with clinical&#xD;
      indicated radial A-lines either planned or already in-situ will be offered participation. The&#xD;
      study will evaluate the accuracy of noninvasive blood pressure measurements with the ANNE One&#xD;
      system to blood pressure readings with the radial A-line.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2023</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean absolute error (MAE) and standard deviation of blood pressure measurements with ANNE One compared to arterial line</measure>
    <time_frame>8 hours</time_frame>
    <description>Mean absolute error and standard deviation between the non-invasive blood pressure measurement provided by the device under test and the invasive blood pressure measurement from the arterial line.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>Comparison of ANNE One system blood pressure measurements to arterial line</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ANNE One</intervention_name>
    <description>Chest sensor for single lead ECG and finger sensor for pulse oximetry.</description>
    <arm_group_label>Comparison of ANNE One system blood pressure measurements to arterial line</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;= 18 years old&#xD;
&#xD;
          -  Ability and willingness to provide written informed consent&#xD;
&#xD;
          -  Admitted for delivery at UNC Medical Center&#xD;
&#xD;
          -  BMI of &gt;= 40 kg/m2&#xD;
&#xD;
          -  Clinically indicated radial A-lines either planned or already in-situ prior to&#xD;
             delivery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Skin sensitivity or allergy that precludes placement of ANNE One&#xD;
&#xD;
          -  Any condition (social or medical) which, in the opinion of the study staff would make&#xD;
             any study participation unsafe or complicate data interpretation&#xD;
&#xD;
          -  Expected delivery within &lt;= 1 hour of arrival to L&amp;D&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sarah E Coughlin</last_name>
    <phone>(224)251-8859</phone>
    <email>sarah.coughlin@sibelhealth.com</email>
  </overall_contact>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>March 15, 2023</study_first_submitted>
  <study_first_submitted_qc>March 15, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2023</study_first_posted>
  <last_update_submitted>March 15, 2023</last_update_submitted>
  <last_update_submitted_qc>March 15, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

